Literature DB >> 16307185

Type II collagen synthesis in the articular cartilage of a rabbit model of osteoarthritis: expression of type II collagen C-propeptide and mRNA especially during early-stage osteoarthritis.

Hiraku Hotta1, Harumoto Yamada, Hironari Takaishi, Tomoyuki Abe, Hideo Morioka, Toshiyuki Kikuchi, Kyosuke Fujikawa, Yoshiaki Toyama.   

Abstract

BACKGROUND: The aim of this study was to observe time course changes in type II collagen synthesis in various regions of articular cartilage affected with osteoarthritis (OA) by examining the expression of type II collagen C-propeptide (pCOL II-C) and mRNA in a rabbit OA model.
METHODS: Osteoarthritis was experimentally induced by partial lateral meniscectomy in the knees of Japanese white rabbits. The cartilage of the animals was then examined histologically over time. The degenerative area of articular cartilage was divided into three areas, according to the degree of degeneration. The ability to synthesize type II collagen was estimated by the immunohistological staining of pCOL II-C and the in situ hybridization of mRNA in type II collagen.
RESULTS: The positive rate of pCOL II-C immunostaining in chondrocytes was highest in the central-degenerative region 1 week after surgery, and the highest rate in the para-degenerative region was observed 2 and 4 weeks after surgery. The percentage of pCOL II-C positive cells increased as the histological degeneration score increased to moderate degeneration and then decreased with further progression of the severity of cartilage degeneration. Examination by in situ hybridization revealed that the regions marked by strong pCOL II-C mRNA expression were similar to those indicated by the immunohistology results.
CONCLUSIONS: These results suggest that the type II collagen-synthesizing potential of chondrocytes is highest in moderately degenerated areas of OA articular cartilage. Cartilage repair continues to be seen even as OA advances, although the reaction varies depending on the stage of OA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307185     DOI: 10.1007/s00776-005-0947-z

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  7 in total

1.  Pathogenetic mechanisms of posttraumatic osteoarthritis: opportunities for early intervention.

Authors:  William C Kramer; Kelly J Hendricks; Jinxi Wang
Journal:  Int J Clin Exp Med       Date:  2011-10-21

2.  Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis.

Authors:  A J Grodzinsky; R M Porter; A G Bajpayee; R E De la Vega; M Scheu; N H Varady; I A Yannatos; L A Brown; Y Krishnan; T J Fitzsimons; P Bhattacharya; E H Frank
Journal:  Eur Cell Mater       Date:  2017-12-05       Impact factor: 3.942

3.  Fourier transform infrared imaging and MR microscopy studies detect compositional and structural changes in cartilage in a rabbit model of osteoarthritis.

Authors:  Xiaohong Bi; Xu Yang; Mathias P G Bostrom; Dorota Bartusik; Sharan Ramaswamy; Kenneth W Fishbein; Richard G Spencer; Nancy Pleshko Camacho
Journal:  Anal Bioanal Chem       Date:  2006-12-02       Impact factor: 4.142

4.  Metabolic regulatory and anti-oxidative effects of modified Bushen Huoxue decoction on experimental rabbit model of osteoarthritis.

Authors:  Wei Liu; Yuan-hao Wu; Xiao-ya Liu; Bin Xue; Wen Shen; Kuo Yang
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

5.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07

6.  Theoretical prediction of ultrasound elastography for detection of early osteoarthritis.

Authors:  Lan Wang; Shigao Chen; Kai-Nan An; Hui-Lin Yang; Zong-Ping Luo
Journal:  ScientificWorldJournal       Date:  2013-11-05

7.  Cellular and molecular changes to chondrocytes in an in vitro model of developmental dysplasia of the hip‑an experimental model of DDH with swaddling position.

Authors:  Bo Ning; Rui Jin; Lin Wan; Dahui Wang
Journal:  Mol Med Rep       Date:  2018-08-13       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.